SCHEMBL33924

SCHEMBL33924

CCC(C)C[C](C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4655171 0.80 TSHR (0.39)
SCHEMBL22401690 0.76 TSHR (0.41)
SCHEMBL7093108 0.75
SCHEMBL1258831 0.75
SCHEMBL3995024 0.75
SCHEMBL4984184 0.75
SCHEMBL7540967 0.75
SCHEMBL20668529 0.75
SCHEMBL19362165 0.75 TSHR (0.35)
SCHEMBL4618906 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 826 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141646-A2 POLYMER DERIVED CERAMICS AND PROCESSES FOR MAKING POLYMER DERIVED CERAMICS OHIO STATE INNOVATION FOUNDATION (US) 2023-07-27 WO claimed
US-20230118751-A1 FUSED RING COMPOUND AND APPLICATION THEREOF WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. (CN) 2023-04-20 US claimed
EP-4079724-A1 FUSED RING COMPOUND AND APPLICATION THEREOF Wuhan LL Science and Technology Development Co., Ltd. (CN) 2022-10-26 EP claimed
EP-3484891-B1 REAGENTS FOR REVERSIBLY PROTECTING BIOLOGICAL MOLECULES BIOMERIEUX SA (FR) 2021-04-14 EP claimed
WO-2020018888-A1 ANTIMICROBIAL PEPTIDES AND METHODS OF USE THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) 2020-01-23 WO claimed
US-10202322-B2 Resorcinol derivatives SUTTER BAY HOSPITALS (US) 2019-02-12 US claimed
US-20180170846-A1 RESORCINOL DERIVATIVES SUTTER WEST BAY HOSPITALS 2018-06-21 US claimed
CN-101538267-B Imidazo [4,5-c ] pyridine compounds and methods of antiviral treatment LEUVEN K U RES & DEV 2015-04-29 CN claimed
US-20130209483-A1 CANNABIDINOID DERIVATIVES SUTTER WEST BAY HOSPITALS (US) 2013-08-15 US claimed
US-20130087745-A1 SOLUBLE PRECURSORS AND SOLUTION-BASED PROCESSES FOR PHOTOVOLTAICS PRECURSOR ENERGETICS, INC. (US) 2013-04-11 US claimed
EP-1276804-B1 LIQUID ANTIOZONANTS AND RUBBER COMPOSITIONS CONTAINING SAME UNIROYAL CHEM CO INC (US) 2006-06-14 EP claimed
US-20050222446-A1 Process for the production of hydrocarbyl silyl carboxylate compounds SIGMA COATINGS B.V. (NL) 2005-10-06 US claimed
EP-1163296-B1 METHOD OF TREATING METALS USING UREIDO SILANES AND MULTI-SILYL-FUNCTIONAL SILANES IN ADMIXTURE CHEMETALL PLC (GB) 2004-12-01 EP claimed
US-6740305-B1 FEEDING PATIENT MEAL INCLUDING, AS BREATH TEST FOOD ADDITIVE SUBSTRATE, LINEAR ACYL AMINOACID PEPTIDOMIMETIC WITH RADIOACTIVE OR NON-RADIOACTIVELY LABELED CARBON ATOM, DETECTING LEVEL OF LABELED CARBON DIOXIDE IN BREATH SAMPLES XANTHUS LIFE SCIENES, INC. 2004-05-25 US claimed
US-6703497-B1 SURFACE MODIFIED BY HAVING HYDROXYL FUNCTIONAL GROUPS PRESENT AT THE SURFACE ETHERIFIED BY ORGANIC COMPOUND COMPRISING SILYLATING AGENT, ISOCYANATE, HALOGENATED ALKYLATING AGENT, ALKYLENE OXIDE, OR GLYCIDYL COMPOUND RHODIA CHIMIE (FR) 2004-03-09 US claimed
EP-1165147-A1 ASSESSMENT OF GASTRIC EMPTYING DISORDERS Phenome Sciences Inc. (US) 2002-01-02 EP claimed
WO-2000061197-A1 ASSESSMENT OF GASTRIC EMPTYING DISORDERS PHENOME SCIENCES INC. (US) 2000-10-19 WO claimed
US-5658918-A INHIBITING NASAL MUCOUS SECRETION NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 1997-08-19 US claimed
EP-0489480-A1 Uracil derivatives and herbicides containing the same as active ingredient NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1992-06-10 EP claimed
EP-0224001-A1 Anthranilonitrile derivatives and related compounds as useful agents for promoting growth, improving feed efficiency, and for increasing the lean meat to fat ratio of warm-blooded animals AMERICAN CYANAMID COMPANY (US) 1987-06-03 EP claimed